Tenet Healthcare Corporation $THC Shares Sold by Bank of New York Mellon Corp

Bank of New York Mellon Corp decreased its position in shares of Tenet Healthcare Corporation (NYSE:THC) by 10.3% in the 4th quarter, according to the company in its most recent Form 13F filing with the SEC. The firm owned 646,397 shares of the company’s stock after selling 74,030 shares during the quarter. Bank of New York Mellon Corp’s holdings in Tenet Healthcare were worth $128,452,000 as of its most recent filing with the SEC.

Several other institutional investors have also bought and sold shares of the stock. Boston Partners lifted its holdings in Tenet Healthcare by 38.8% in the third quarter. Boston Partners now owns 3,147,555 shares of the company’s stock worth $638,958,000 after purchasing an additional 880,413 shares during the period. Ameriprise Financial Inc. lifted its holdings in Tenet Healthcare by 8.0% in the second quarter. Ameriprise Financial Inc. now owns 2,119,423 shares of the company’s stock worth $373,020,000 after purchasing an additional 157,109 shares during the period. AQR Capital Management LLC lifted its holdings in Tenet Healthcare by 62.3% in the third quarter. AQR Capital Management LLC now owns 1,876,423 shares of the company’s stock worth $380,989,000 after purchasing an additional 720,160 shares during the period. Norges Bank acquired a new stake in Tenet Healthcare in the fourth quarter worth about $248,494,000. Finally, Eminence Capital LP acquired a new stake in Tenet Healthcare in the third quarter worth about $225,263,000. Institutional investors and hedge funds own 95.44% of the company’s stock.

Wall Street Analyst Weigh In

Several equities analysts have recently weighed in on the stock. UBS Group raised their price objective on shares of Tenet Healthcare from $260.00 to $288.00 and gave the company a “buy” rating in a research report on Thursday, February 12th. Guggenheim lowered their price objective on shares of Tenet Healthcare from $283.00 to $252.00 and set a “buy” rating on the stock in a research note on Friday, May 1st. KeyCorp lowered their price objective on shares of Tenet Healthcare from $250.00 to $225.00 and set an “overweight” rating on the stock in a research note on Friday, May 1st. Wall Street Zen cut shares of Tenet Healthcare from a “strong-buy” rating to a “buy” rating in a research note on Monday, May 11th. Finally, Stephens lowered their price objective on shares of Tenet Healthcare from $275.00 to $260.00 and set an “overweight” rating on the stock in a research note on Monday, May 4th. Eighteen analysts have rated the stock with a Buy rating and four have assigned a Hold rating to the stock. According to data from MarketBeat.com, the company has a consensus rating of “Moderate Buy” and an average price target of $244.16.

Tenet Healthcare Price Performance

NYSE THC opened at $162.20 on Friday. The stock’s 50-day moving average price is $186.17 and its two-hundred day moving average price is $200.75. The company has a current ratio of 1.36, a quick ratio of 1.30 and a debt-to-equity ratio of 1.96. The company has a market cap of $13.97 billion, a PE ratio of 8.43, a PEG ratio of 1.33 and a beta of 1.28. Tenet Healthcare Corporation has a 1 year low of $146.60 and a 1 year high of $247.21.

Tenet Healthcare (NYSE:THC) last posted its quarterly earnings data on Thursday, April 30th. The company reported $4.82 earnings per share (EPS) for the quarter, topping the consensus estimate of $4.21 by $0.61. The firm had revenue of $5.37 billion for the quarter, compared to the consensus estimate of $5.39 billion. Tenet Healthcare had a return on equity of 25.55% and a net margin of 7.94%.The business’s revenue for the quarter was up 2.6% compared to the same quarter last year. During the same quarter in the previous year, the company earned $4.36 EPS. Tenet Healthcare has set its FY 2026 guidance at 16.380-18.68 EPS. On average, analysts predict that Tenet Healthcare Corporation will post 17.61 EPS for the current year.

Insiders Place Their Bets

In other news, Director Nadja West sold 3,000 shares of the company’s stock in a transaction dated Wednesday, May 27th. The stock was sold at an average price of $177.35, for a total value of $532,050.00. Following the transaction, the director owned 24,805 shares in the company, valued at $4,399,166.75. This represents a 10.79% decrease in their position. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available at this link. Also, EVP Thomas W. Arnst sold 8,000 shares of the company’s stock in a transaction dated Monday, March 9th. The shares were sold at an average price of $238.85, for a total value of $1,910,800.00. Following the completion of the transaction, the executive vice president owned 12 shares in the company, valued at $2,866.20. This represents a 99.85% decrease in their position. Additional details regarding this sale are available in the official SEC disclosure. Insiders have sold 23,138 shares of company stock worth $4,976,589 over the last quarter. Company insiders own 0.97% of the company’s stock.

Tenet Healthcare Company Profile

Tenet Healthcare Corporation (NYSE: THC) is a diversified American healthcare services company that owns and operates acute care hospitals and a broad range of outpatient facilities. Its portfolio includes general acute-care hospitals, specialty hospitals, ambulatory surgery centers, urgent care and diagnostic imaging centers, and other ancillary service locations. Tenet’s operations are oriented around delivering inpatient and outpatient clinical care across multiple medical specialties, with an emphasis on surgical services, emergency care, and advanced diagnostics.

In addition to facility-based care, Tenet provides integrated services designed to support clinical operations and improve patient access and care coordination.